| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/20/2000 | CN1056512C Medicine for treatment of trigeminal neuralgia |
| 09/19/2000 | US6121479 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics |
| 09/19/2000 | US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides |
| 09/19/2000 | US6121375 Gels formed by the interaction of poly(aldehyde) with various substances |
| 09/19/2000 | US6121326 Antiinflammatory agents; antiallergens; analgesics; antiemetics |
| 09/19/2000 | US6121322 Antiinflammatory agents |
| 09/19/2000 | US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 09/19/2000 | US6121317 Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing |
| 09/19/2000 | US6121316 2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 09/19/2000 | US6121305 5,5'-dihydroxy-4,4'-bipyrazole compounds of given formula; free radical scavenger; use to treat cerebral ischemia, heart disease, carcinoma, aging, inflammation or digestive system disease, or in detection of an active oxygen or free radicals |
| 09/19/2000 | US6121287 Quinoline derivatives |
| 09/19/2000 | US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders |
| 09/19/2000 | US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders |
| 09/19/2000 | US6121272 Bidentate metalloprotease inhibitors |
| 09/19/2000 | US6121266 Pyridazines as interleukin-1β converting enzyme inhibitors |
| 09/19/2000 | US6121253 Prostaglandin conjugates for treating or preventing bone disease |
| 09/19/2000 | US6121243 Prophylaxis of skin against ageing, against inflammation and for protection from photoreaction and oxidative influences |
| 09/19/2000 | US6121240 Urokinase receptor ligands |
| 09/19/2000 | US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents |
| 09/19/2000 | US6120752 Vial equipped with dispensing valve |
| 09/19/2000 | CA2184914C Isoxazoline compounds as 5-lipoxygenase inhibitors |
| 09/19/2000 | CA2106768C Bradykinin type peptides |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases |
| 09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
| 09/14/2000 | WO2000053608A1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 09/14/2000 | WO2000053605A1 Tyrosine kinase inhibitors |
| 09/14/2000 | WO2000053604A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | WO2000053600A1 Novel piperidine derivatives |
| 09/14/2000 | WO2000053596A2 Imidazole compounds as histamine h3 ligands |
| 09/14/2000 | WO2000053572A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor |
| 09/14/2000 | WO2000053568A1 Sphingoid base derivatives and uses thereof |
| 09/14/2000 | WO2000053233A1 Use of protein conformation for the protection and release of chemical compounds |
| 09/14/2000 | WO2000053228A2 Use of niaouli essential oil as transdermal permeation enhancer |
| 09/14/2000 | WO2000053223A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | WO2000053194A1 Remedies for joint diseases |
| 09/14/2000 | WO2000053177A1 Liposome preparations |
| 09/14/2000 | WO2000037504A3 Human monoclonal antibodies to ctla-4 |
| 09/14/2000 | WO2000037056A3 Composition and method for treating glaucoma |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation |
| 09/14/2000 | CA2367315A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases |
| 09/14/2000 | CA2366644A1 Tyrosine kinase inhibitors |
| 09/14/2000 | CA2366642A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | CA2364257A1 Liposome preparations |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2362319A1 Imidazole compounds as histamine h3 ligands |
| 09/13/2000 | EP1035115A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 09/13/2000 | EP1035110A1 Benzylaminodiacetamide derivatives, compositions containing the same, process for their preparation and uses |
| 09/13/2000 | EP1034185A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 09/13/2000 | EP1034174A1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1034163A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them |
| 09/13/2000 | EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 09/13/2000 | EP1033983A1 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0817787A4 Nitrogenous macrocyclic compounds |
| 09/13/2000 | EP0764166B1 Corticotropin releasing factor antagonists |
| 09/13/2000 | CN1266434A 1,2,4-triazolo [4,3-B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them |
| 09/13/2000 | CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 09/13/2000 | CN1266368A Heterocyclic vinylethers against neurological disorders |
| 09/13/2000 | CN1265896A Capsule for treating arthritis and strengthening physique |
| 09/13/2000 | CN1056373C Process for preparation of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 09/12/2000 | US6118001 Anticancer agent; antiarthritic agent |
| 09/12/2000 | US6117900 Use of retigabine for the treatment of neuropathic pain |
| 09/12/2000 | US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 09/12/2000 | US6117895 Dialkoxyphenyl-substituted oxazolidinones |
| 09/12/2000 | US6117887 Inhibition of 26S and 20S proteasome by indanones |
| 09/12/2000 | US6117874 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4 ) antagonists |
| 09/12/2000 | US6117840 Inhibits binding between vla-4 receptor expressed on inflammatory leukocytes and fibronectin cs-1 peptide expressed on endothelial cells that are involved in immunoinflammatory disease states |
| 09/12/2000 | US6117836 Glycosylation-mediated inhibition of factor X |
| 09/12/2000 | US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents |
| 09/12/2000 | US6117445 Administration of an a1 adenosine receptor antagonist, or p2x purinoceptor or a compination of both offer potential as an antifibrotic or antisclerotic treatment |
| 09/12/2000 | US6117421 Method for promoting cell growth and immunosuppression using chaperonin |
| 09/08/2000 | WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 09/08/2000 | WO2000052032A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000052008A1 Pyrazolopyridines |
| 09/08/2000 | WO2000051988A1 Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity |
| 09/08/2000 | WO2000051968A1 Method for the preparation of a chiral-beta-amino ester |
| 09/08/2000 | WO2000051686A1 Use of integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia |
| 09/08/2000 | WO2000051685A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| 09/08/2000 | WO2000051645A1 Polymer compositions for polynucleotide delivery |
| 09/08/2000 | WO2000051595A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | WO2000051575A1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| 09/08/2000 | WO2000037472A3 Substituted pirroloindoles |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000016756A3 Use of n-acylvanillinamide derivatives as agonists of peripheral cannabinoid cb1 receptors |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | WO2000010526A3 New oral formulation for 5-ht4 agonists or antagonists |
| 09/08/2000 | CA2366852A1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| 09/08/2000 | CA2364127A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| 09/08/2000 | CA2364006A1 Polymer compositions for polynucleotide delivery |
| 09/08/2000 | CA2362911A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 09/08/2000 | CA2362489A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |